Rhenium-188 SSS Lipiodol

Rhenium-188 labeled Lipiodol

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rhenium-188 SSS Lipiodol, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2) [Phase 2]